An open-label study of the effect of milnacipran on depression scores in patients with major depression not responding to SSRI treatment.
Phase of Trial: Phase IV
Latest Information Update: 23 Feb 2010
At a glance
- Drugs Milnacipran (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors Roche
- 21 Feb 2008 New trial record.